<DOC>
	<DOCNO>NCT00698191</DOCNO>
	<brief_summary>This study explore new approach treat patient medical condition know systemic lupus erythematosus ( SLE ) resistant previous treatment use new population cell capability restore normal immune system longer attack body . The stated hypothesis SLE condition cause abnormal immune system restore replenish body new population progenitor cell .</brief_summary>
	<brief_title>Mesenchymal Stem Cells Transplantation Refractory Systemic Lupus Erythematosus ( SLE )</brief_title>
	<detailed_description>The purpose study evaluate safety efficacy allogeneic bone marrow derive mesenchymal stem cell ( AlloMSC ) transplantation patient refractory SLE . Patients Lupus nephritis refractory corticosteroid cyclophosphamide trial enrol trial . The treatment intervention include 24 hour pretreatment cyclophosphamide follow AlloMSC transplantation . Patients admit in-patient service 3-5 day transplant treatment follow outpatient clinic . All baseline lupus serology , renal function panel obtain pre-treatment admission . Post-transplantation follow-up visit monthly interval lupus serology renal function test , every 3 month analysis T regulatory population . The transplanted patient evaluate integrated team rheumatologist , hematologists bone marrow transplant specialist every month entire duration trial ( 2 year ) every 6-12 month thereafter .</detailed_description>
	<mesh_term>Lupus Erythematosus , Systemic</mesh_term>
	<criteria>All patient fulfil American College Rheumatology ( ACR ) criterion SLE , man woman age 15 70 year old , SLEDAI≥8 ; Lupus nephritis 24h urine protein≥1g ; Refractory disease determine failure follow regimen : Trial corticosteroid ( oral prednisone 20 mg/day ) ; Trial cyclophosphamide 0.4 ~ 0.6 / m2 every two week six month , immunosuppressive drug , MMF 2 g / day , three month ; Patients must sign informed consent indicate aware investigational nature study keep policy hospital ; Willing use contraception throughout study 12 mo follow treatment . Abnormal liver function ( ALT high 3 time normal value ) ; Endstage renal failure ; Severe heart pulmonary failure , important organ damage ; Undercontrolled infection Pregnant breast feed woman , male female intend recent pregnancy .</criteria>
	<gender>All</gender>
	<minimum_age>15 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>June 2008</verification_date>
	<keyword>Lupus Erythematosus , Systemic</keyword>
	<keyword>Lupus Nephritis</keyword>
	<keyword>Mesenchymal Stem Cells</keyword>
	<keyword>Transplantation</keyword>
</DOC>